Navigation Links
Issue Brief Addresses Stage 2 Meaningful Use Patient Education and Engagement Initiatives
Date:12/6/2012

RALEIGH, N.C., Dec. 6, 2012 /PRNewswire/ -- Now that The Centers for Medicare and Medicaid Services (CMS) have issued their final mandates for achieving Stage 2 meaningful use requirements, hospitals are working quickly to make the short-term adjustments and longer-term changes needed to satisfy the new rules. Acknowledging the challenges hospitals face, CMS has delayed the onset of Stage 2 criteria for eligible hospitals to fiscal year 2014, but many hospitals already have implemented—or are taking steps for achieving—several of the new initiatives to improve patient engagement.

Beyond improved clinical outcomes and patient satisfaction, the incentive currently driving meaningful use is the government subsidies for implementing the technology and compliance changes. Although compliance is currently primed through financial incentives, non-compliance in the future will result in withheld reimbursements for hospitals, healthcare organizations, and physicians who do not achieve meaningful use standards within the required timeframe.

The second in a series of three issue briefs from TeleHealth Services examines how improved patient education, engagement, and interactivity tools are helping to increase compliance and understanding, enhancing care coordination, measuring service responsiveness, and improving clinical outcomes such as reduced readmissions, better post-discharge planning, and improved patient-satisfaction ratings.

The Stage 2 criteria emphasize health information exchange between providers to improve care coordination for patients. Although clinical quality measure (CQM) reporting has been removed as a core objective for eligible hospitals, all providers are required to report on CQMs in order to demonstrate meaningful use. Beginning in 2014, hospitals must report on 16 out of 29 total CQMs, selecting CQMs from at least three of the six key health care policy domains recommended by the Department of Health and Huma
'/>"/>

SOURCE TeleHealth Services
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. CSL Behring Parent Company, CSL Limited, Issues Fourth Corporate Responsibility Report
2. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
3. Emmaus CEO Yutaka Niihara, M.D., Issues Statement In Connection with Status of Companys Phase III FDA Sickle Cell Treatment Trials
4. TissueGene Completes Enrollment in U.S. Phase II Study of TG-C in Patients with Knee Osteoarthritis
5. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
6. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
7. Southern Home Medical Once Again Reduces The Companys Issued And Outstanding Preferred Shares
8. Zi Xiu Tang Success, LLC Issues Voluntary Nationwide Recall of Classic Zi Xiu Tang Bee Pollen Capsules and Ultimate Formula Capsules due to Undeclared Sibutramine
9. CORRECTION: Star Scientific Issues Statement Correcting the Underreporting of the "Flint" CRP Human Study Results
10. Terso Solutions partners with Champion Medical Technologies to offer fully automated tracking of Tissue and Implantable Devices
11. Qualitest Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014  Global Discovery Biosciences, a ... some of the biggest healthcare challenges, announces their collaboration ... accurate blood test for the early detection of lung ... of cancer death. Typically, the symptoms and subsequent diagnosis ... cancer, where the chance of a cure has already ...
(Date:9/23/2014)... 2014  Decision Resources Group finds that ... criteria and payer requirements in key pharmaceutical ... country, allow pharma to leverage similar payer ... access is extremely complex, with each country ... challenges—and a vast variety of local authorities ...
(Date:9/23/2014)... Calif. , Sept. 23, 2014 This test ... risk event. A "risk event" is defined by activities that can ... transfusions, tattoos, or use of any shared needles. ... HIV-2) in oral fluid. This HIV test works by looking ... Provides results in 20 minutes, enabling patients to learn ...
Breaking Medicine Technology:Global Discovery Biosciences Announces Collaboration with IPMD, Inc. to Develop Innovative Aptamer-Based Blood Test for the Early Detection of Lung Cancer 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4WholeHealth Products announces the release of the FDA Cleared "HIV 1&2" Rapid Diagnostic Test for Professional and Retail 2
... Va., Aug. 30, 2011 Dilon expands its ... alliance with PenRad, rated #1 Mammography Information System ... innovation, high quality and customer loyalty are the ... provide leading-edge breast imaging tools, and an information ...
... announced the results of its Comprehensive Client Performance ... a 19 percent increase in their total revenue ... go-live. SuccessEHS believes this increase in revenue directly ... conjunction with the implementation of SuccessEHS software and ...
Cached Medicine Technology:Dilon Diagnostics® Partners With PenRad® 2Dilon Diagnostics® Partners With PenRad® 3SuccessEHS Solution Leads to 19 Percent Increase in Revenue 2SuccessEHS Solution Leads to 19 Percent Increase in Revenue 3
(Date:9/23/2014)... Karen Pallarito HealthDay Reporter ... and hospitals got paid for providing better care, ... for making informed health choices. A new report ... The report, from the IMS Institute for Healthcare Informatics ... events expected to alter the delivery of health care and ...
(Date:9/23/2014)... bringing with its advances promises of individualized genetic ... interventions. Genetic tests are already guiding treatments ... c virus (HPC), and emerging research is showing ... an individual,s susceptibility to addiction to a substance, ... there appear to be many benefits inherent in ...
(Date:9/23/2014)... September 23, 2014 Grinnell Mutual ... improvement projects in the Midwest. Working Together Making ... three non-profit organizations with projects positively impacting their ... rural marketplace make their communities a better places,” ... and Community Relations Barb Baker. “Their leadership—as coaches, ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- The number ... prescription drugs is growing, so doctors need to ... and Drug Administration warned Tuesday. In a ... widespread that it has launched a program to ... administrators about proper drug purchasing procedures. The program ...
(Date:9/23/2014)... the benefits of preventing a reduction in the ... released today by the American College of Physicians ... the Medicaid Primary Care Pay Parity Program: Unless ... Primary Care Will Expire," explains why it is ... and pediatricians (and their related subspecialists), family physicians, ...
Breaking Medicine News(10 mins):Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3
... cancer when it works with,the growth-promoting protein IL-3 and ... Tenn., Nov. 27 A gene called N-Myc,leads a ... is overexpressed,helping to trigger acute myeloid leukemia (AML) under ... conditions, according to,results of a mouse study done by ...
... CHAPEL HILL, N.C., Nov. 27 A story ... "colleague spam" -- the habit of,co-workers indiscriminately hitting ... New research by benchmarking leader Best Practices, LLC,uncovered ... spam" -- the,tendency of organizations to send redundant ...
... Failing Marks for Second Straight Year, WASHINGTON, Nov. ... Report Card on Lung Cancer. This,Report is an assessment ... state of Georgia. LCA-GA is a chapter of Lung ... patient support and,advocacy for people living with or at ...
... Nov. 27 The Aesthetic Extender,Symposium announced its inaugural ... which will be held in Miami Beach,Florida on October ... the first,and only event of its kind. Unlike other ... its mission statement a goal of adhering to,the policies ...
... Nov. 27 A new, free white ... on choosing the,right electronics manufacturing services (EMS) ... to download at, http://www.federalelec.com/medicalpaper ., Medical ... consistent quality and,conformance to product and regulatory ...
... E.S.T. - Positron emission tomography (PET) is a useful ... staging of lung cancer and improved treatment for patients, ... Journal of National Cancer Institute. , The ... of Cancer Care Ontarios Program in Evidence-Based Care led ...
Cached Medicine News:Health News:St. Jude Researchers Identify Key Genetic Trigger of Acute Myeloid Leukemia 2Health News:Using Efficient Communication to Boost Pharma Sales Force Productivity 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 2Health News:Lung Cancer Alliance-Georgia Issues Second Annual State-Specific Report Card on Lung Cancer 3Health News:White Paper Details How to Choose the Right EMS Provider for Medical Products Outsourcing 2Health News:PET imaging significantly enhances standard imaging in lung cancer staging 2
The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
Inquire...
... can be used for a variety of vacuum needs ... or volatile fumes., Quiet running operation ... changes forever , Chemically Resistant ... solvents such as acids and organics. ...
High-intensity 300-watt xenon lamp, with continuously adjustable output from 0 to 100% manually or automatically by camera video output signal....
Medicine Products: